CDA and colorectal cancer: The authors then investigated if overexpressing CDA in the anti-PD-1-responsive colorectal cancer model, MC38, could induce ICI resistance and found that these cells now displayed elevated aggression and resistance to anti-PD-1 therapy due to poor T cell response induction [9].